RPA3 and melanoma: CRISPRi functionality in melanoma cell lines was further confirmed by an sgRNA co-expressed with GFP in a competition assay in which two (501mel) or one (WM1361a) sgRNA was targeting the essential cell survival gene RPA3 (15).